Literature DB >> 9538161

Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring.

L Hilakivi-Clarke1, E Cho, R Clarke.   

Abstract

Human and animal data indicate that a high maternal estrogen exposure during pregnancy increases breast cancer risk among daughters. This may reflect an increase in the epithelial structures that are the sites for malignant transformation, i.e., terminal end buds (TEBs), and a reduction in epithelial differentiation in the mammary gland. Some phytoestrogens, such as genistein which is a major component in soy-based foods, and zearalenone, a mycotoxin found in agricultural products, have estrogenic effects on the reproductive system, breast and brain. The present study examined whether in utero exposure to genistein or zearalenone influences mammary gland development. Pregnant mice were injected daily with i) 20 ng estradiol (E2); ii) 20 microg genistein; iii) 2 microg zearalenone; iv) 2 microg tamoxifen (TAM), a partial estrogen receptor agonist; or v) oil-vehicle between days 15 and 20 of gestation. E2, genistein, zearalenone, and tamoxifen all increased the density of TEBs in the mammary glands. Genistein reduced, and zearalenone increased, epithelial differentiation. Zearalenone also increased epithelial density, when compared with the vehicle-controls. None of the treatments had permanent effects on circulating E2 levels. Maternal exposure to E2 accelerated body weight gain, physical maturation (eyelid opening), and puberty onset (vaginal opening) in the female offspring. Genistein and tamoxifen had similar effects on puberty onset than E2. Zearalenone caused persistent cornification of the estrus smears. These findings indicate that maternal exposure to physiological doses of genistein mimics the effects of E2 on the mammary gland and reproductive systems in the offspring. Thus, our results suggest that genistein acts as an estrogen in utero, and may increase the incidence of mammary tumors if given through a pregnant mother. The estrogenic effects of zearalenone on the mammary gland, in contrast, are probably counteracted by the permanent changes in estrus cycling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538161     DOI: 10.3892/or.5.3.609

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-12

2.  Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.

Authors:  John T Szilagyi; Ludwik Gorczyca; Anita Brinker; Brian Buckley; Jeffrey D Laskin; Lauren M Aleksunes
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

Review 3.  Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood.

Authors:  Suzanne E Fenton; Casey Reed; Retha R Newbold
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-10-19       Impact factor: 13.820

4.  In Vitro Screening of Environmental Chemicals Identifies Zearalenone as a Novel Substrate of the Placental BCRP/ABCG2 Transporter.

Authors:  Jingcheng Xiao; Qi Wang; Kristin M Bircsak; Xia Wen; Lauren M Aleksunes
Journal:  Toxicol Res (Camb)       Date:  2015-05-01       Impact factor: 3.524

5.  Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity.

Authors:  John T Szilagyi; Anna M Vetrano; Jeffrey D Laskin; Lauren M Aleksunes
Journal:  Placenta       Date:  2017-04-12       Impact factor: 3.481

6.  Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance.

Authors:  Jennifer D Cook; Barbara J Davis; Sheng-Li Cai; J Carl Barrett; Claudio J Conti; Cheryl Lyn Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

7.  Birth weight and other prenatal factors and risk of breast cancer in Asian-Americans.

Authors:  Anna H Wu; Roberta McKean-Cowdin; Chiu-Chen Tseng
Journal:  Breast Cancer Res Treat       Date:  2011-06-28       Impact factor: 4.872

8.  Urinary mycoestrogens, body size and breast development in New Jersey girls.

Authors:  Elisa V Bandera; Urmila Chandran; Brian Buckley; Yong Lin; Sastry Isukapalli; Ian Marshall; Melony King; Helmut Zarbl
Journal:  Sci Total Environ       Date:  2011-10-04       Impact factor: 7.963

Review 9.  Review of the environmental prenatal exposome and its relationship to maternal and fetal health.

Authors:  Julia E Rager; Jacqueline Bangma; Celeste Carberry; Alex Chao; Jarod Grossman; Kun Lu; Tracy A Manuck; Jon R Sobus; John Szilagyi; Rebecca C Fry
Journal:  Reprod Toxicol       Date:  2020-02-23       Impact factor: 3.143

Review 10.  Endocrine disruption of the epigenome: a breast cancer link.

Authors:  Kevin C Knower; Sarah Q To; Yuet-Kin Leung; Shuk-Mei Ho; Colin D Clyne
Journal:  Endocr Relat Cancer       Date:  2014-03-12       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.